Everest Medicines Ltd (HKSE:01952)
HK$ 44.65 4.05 (9.98%) Market Cap: 14.39 Bil Enterprise Value: 11.54 Bil PE Ratio: 0 PB Ratio: 3.03 GF Score: 41/100

Everest Medicines Ltd New Strategy Launch Call Transcript

Jan 03, 2023 / 12:00PM GMT
Release Date Price: HK$18.38 (+5.75%)
Operator

Good day, and thank you for standing by. Welcome to Everest Medicine's New Corporate Strategy Launch Conference Call. Please be advised that today's conference is being recorded. (Operator Instructions) At this time, I would like to hand the conference over to your speaker today, Ms. Leah Liu, VP of Corporate Affairs. Please go ahead. Thank you.

Leah Liu
Everest Medicines Limited - Joint Company Secretary

Thank you, operator. Hi, everyone. Welcome to our New Corporate Strategy Launch Conference Call. Joining us today are Mr. Rogers Luo, our new CEO, of Everest Medicines; Mr. Ian Woo, our President and Chief Financial Officer; and Dr. Zhengying Zhu, our CMO for Internal Medicine.

Before we get started, I would like to remind you that the speakers of this conference call may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the company or its officers with respect to the business operations and financial conditions of the company, which can be identified by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot